Health

Celltrion USA announces incorporation of adalimumab-aaty, a Humira® biosimilar, to the Costco Member Prescription Program

* Adalimumab-aaty was first approved by the Food and Drug Administration on May 23, 2023 and became commercially available among key distributors across the U.S. onJuly 2, 2023 * Adalimumab-aaty's inclusion creates greater accessibility to treatments for Americans with inflammatory conditions...

2024-08-13 07:46 1598

Environmental Compliance and Pharmaceutical Quality Standards Pave the Way for Transformational Growth in Chromatography

SAN ANTONIO, Aug. 13, 2024 /PRNewswire/ -- Chromatography instruments and modular test equipment are revolutionising scientific analysis and industrial testing. By enabling precise separation and analysis of complex mixtures, chromatography plays a crucial role in ensuring pharmaceutical purity, ...

2024-08-13 01:30 1678

OcuMension acquires rights to Alcon eye drops in exchange for a 16.7% equity stake, signaling the commencement of comprehensive strategic relationship

SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 13th 2024, Ocumension Therapeutics ("OcuMension") announced an agreement with Alcon Inc. ("Alcon", and collectively with OcuMension, the "Parties") where OcuMension will acquire or secure commercialization rights inChina to a portfolio of Alcon dr...

2024-08-12 22:01 2497

Mabwell's Novel Nectin-4 Targeting ADC 9MW2821 Granted Breakthrough Therapy Designation by China's NMPA

SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced its novel Nectin-4 targeting ADC (R&D code: 9MW2821) has been granted Breakthrough Therapy Designation (BTD) bythe Center for Drug Evaluation (CDE) of China's...

2024-08-12 22:00 1918

Momcozy's Ongoing Campaign for Breastfeeding Awareness Month Connects Moms and Breaks Barriers

NEW YORK, Aug. 12, 2024 /PRNewswire/ -- During Breastfeeding Awareness Month, global mother and baby brandMomcozy hosts a campaign to empower mothers and break down breastfeeding barriers. Fe...

2024-08-12 22:00 1207

Ocumension (01477.HK) Demonstrates Strong Operational Resilience, Commercialization Capabilities Reach New Heights

SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- On August 12, Ocumension Therapeutics ( Shanghai) Co., Ltd. (01477.HK, hereinafter referred to as "Ocumension" or the "Company") released its 2024 Interim Results Report. During the reporting period, the company achieved operating revenue ofRMB 168 million, ...

2024-08-12 21:52 3023

Xiao-I Corporation Showcases Hearview Smart Glasses at Successful U.S. Launch Event

SHANGHAI, Aug. 12, 2024 /PRNewswire/ -- Xiao-I Corporation ("Xiao-I" or the "Company") (NASDAQ: AIXI), a leading artificial intelligence company, is proud to announce the successful U.S. launch of its innovative Hearview Smart Glasses. The event, which was streamed live on YouTube onAugust 8th at...

2024-08-12 21:30 2874

VISEN Pharmaceuticals announced that the Phase 3 PaTHway China Trial of Palopegteriparatide achieved primary and key secondary endpoints in the treatment of adults with hypoparathyroidism

* 77.6% of patients treated with palopegteriparatide in the PaTHway China Trial achieved the primarymulti-component endpoint compared to 0.0% for placebo (p <0.0001) *  Palopegteriparatide was generally safe and well-tolerated, with no discontinuations related to study drug. SHANGHAI, Aug. 12...

2024-08-12 21:00 1799

Actinogen announces achievement of clinically and statistically significant superiority of Xanamem® over placebo on depression in XanaCIDD phase 2a trial

There was a clinically meaningful and persistent improvement depression measured by the key secondary endpoint of MADRS.[1] The primary endpoint of superiority to placebo in a cognitive "attention composite" of three Cogstate computerized tests was not met with large improvements seen in both Xan...

2024-08-12 20:30 1817

AXA Study: Hong Kong workers buckling under high stress and poor mind health

More than 3 in 4 Hong Kong workers face mind health issues at work, with nearly half taking sick leave HONG KONG, Aug. 12, 2024 /PRNewswire/ -- The majority of the working population inHong Kong suffers from multiple mental health problems related to work, and disengagement is alarmingly high, a...

2024-08-12 18:19 2099

FEELING FOGGY, DISTRACTED, DEMOTIVATED? DON'T LET BRAIN FATIGUE HOLD YOU BACK

* Brain fatigue causes symptoms like forgetfulness and difficulty concentrating. * BRAND'S® Essence of Chicken unlocks the crucial link between diet and brain fatigue, highlighting the importance of amino acids for brain health. KUALA LUMPUR, Malaysia, Aug. 12, 2024 /PRNewswire/ -- Have you e...

2024-08-12 16:00 1618

Sumedang Regency and Docquity Launch AI-Driven Health Platform to Tackle Tuberculosis, Stunting, and Hypertension

SUMEDANG, Indonesia, Aug. 12, 2024 /PRNewswire/ -- Docquity, a leading health tech company established in 2015, is proud to announce its expansion into the B2G sector with the launch of the Puskesmas AI platform in partnership with Sumedang Regency,West Java. This initiative builds on the success...

2024-08-12 15:00 1856

Milestone: Renal Nerve Mapping / Selective Renal Denervation (msRDN) System by SyMap Medical Ltd Approved for Treatment of Uncontrolled Hypertension in China

SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- On August 6, 2024, the msRDN System (SyMapCath I®/ SYMPIONEER S1®), developed by Suzhou/China-based SyMap Medical Ltd. (SyMap Medical), was approved by the National Medical Products Administration (NMPA) ofChina and granted a Class III Medical Devices ...

2024-08-12 13:55 1361

IASO Bio Receives U.S. FDA Approval of Investigational New Drug Application for Equecabtagene Autoleucel for Two New Autoimmune Disease Indications

SHANGHAI, NANJING, China and SAN JOSE, Calif., Aug. 12, 2024 /PRNewswire/ -- IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing innovative cell therapy and antibody products, today announced that the investigation...

2024-08-12 13:52 1435

German Stem Cell Expert Leads Delegation to Boost Sino-German Health & Educational Cooperation

BAODING, China, Aug. 12, 2024 /PRNewswire/ -- A landmark German delegation, led by world-renowned stem cell expert Prof. Dato' Sri Dr.Mike Chan, concluded a three-day visit to Baoding,China, marking a significant step in international health cooperation. The visit, fromJuly 11-13, reciprocated an...

2024-08-12 12:08 1869

The San Ignacio Hospital project in Peru was officially handed over

BEIJING, Aug. 11, 2024 /PRNewswire/ -- On 1 August local time, the San Ignacio Hospital project inPeru, constructed by POWERCHINA, successfully passed the final acceptance of the owner and obtained the official handover certificate. This project is the first hospital project formally handed over ...

2024-08-12 10:55 2377

Hong Kong Breast Cancer Foundation charity walk "Pink Walk 2024" - "Walk for Breast Cancer, Together We Can"

20 October at The Peak HONG KONG, Aug. 12, 2024 /PRNewswire/ -- The Hong Kong Breast Cancer Foundation (HKBCF), is delighted to announce that its annual signature fundraising event"Pink Walk 2024" will take place on 20 October 2024 (Sunday) at The Peak,Hong Kong Island. Themed "Walk for Breast C...

2024-08-12 10:45 1624

Alphamab Oncology to Present the Latest Clinical Data of Anti-HER2 Bispecific ADC JSKN003 at the ESMO Congress 2024

SUZHOU, China, Aug. 12, 2024 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announced that the latest clinical data from two studies on anti-HER2 bispecific antibody-drug conjugate (ADC) JSKN003 in patients with platinum-resistant ovarian cancer and patients with advanced HER2-positive (...

2024-08-12 10:18 1825

AsiaMedic launches customised AI virtual assistantwith Enterprise SG affiliated startup MIEA Health

* WhatsApp integrated AI virtual assistant expected to reduce call handling time, enabling AsiaMedic to serve its customers more efficiently and effectively. SINGAPORE, Aug. 12, 2024 /PRNewswire/ -- SGX Catalist-listed AsiaMedic Limited (the "Company" and together with its subsidiaries, the "Gr...

2024-08-12 06:00 2234

GenScript Biotech Reports First Half 2024 Results

Strong Revenue Growth and Strategic Advances Across Key Segments, Enhances Commitment to ESG and Sustainable Development  * Impressive Financial Growth: The group reported a 43.5% increase in revenue, driven by a 156% boost in cell therapy revenue and a 75.4% rise in gross profit, showcasing s...

2024-08-09 23:19 3744
1 ... 45464748495051 ... 858